RICHARD D. PEARSON, M.D.; RICHARD L. GUERRANT, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Due to mistakes made after the galley proofs were corrected, the abstract of our report, "Praziquantel: A Major Advance in Anthelminthic Therapy" (1), incorrectly implies that praziquantel has been approved in the United States for the treatment of helminthic infections other than schistosomiasis. Praziquantel has been released in the United States only for the treatment of schistosomiasis, and its use for other helminthic infections, although very promising, is still investigational. Also, mistakenly deleted from our paper is the inference that metrifonate and oxammiquine, which are less expensive than praziquantel but equally effective for the treatment of S.
PEARSON RD, GUERRANT RL. Correction: Praziquantel and Schistosomiasis Treatment. Ann Intern Med. 1983;99:574. doi: 10.7326/0003-4819-99-4-574_4
Download citation file:
Published: Ann Intern Med. 1983;99(4):574.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use